CheckMyRecalls

Houston Rx LLC recalls Sermorelin and 1 more

Published
21 Oct 2026
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Lack of process control

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Sermorelin, 1 mg/mL, 10 ml vial, Sterile injectable solution, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.

Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.

Brand / company
Houston Rx LLC
Codes / lots
Lot# SER-081726-1-10, Beyond Use Date: 10/01/2026. | Lot# TZN-080326-20/2-2, Beyond Use Date: 12/01/2026.
Distribution
Nationwide in the USA.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 21 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.